Catalytic fold of WT PARG1 C1-GAP domain for RhoA interaction. حسب Zen Kouchi (14898435)

BMI groups by SES. حسب Krystal Hunter (6820052)

الموضوعات:

BMISES_Data_Part2. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for HSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for overall population. حسب Krystal Hunter (6820052)

الموضوعات:

BMISES_Data_Part1. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of HSES/LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of overall population. حسب Krystal Hunter (6820052)

الموضوعات:

Diagram of study population. حسب Krystal Hunter (6820052)

الموضوعات:

National (A) Medicare prescription rates per thousand Part D enrollees and (B) Medicare spending for clozapine gradually decreased for 2015-2020. حسب Luke R. Cavanah (19022435)

الموضوعات:

Effects of busulfan treatment on the ultrastructure of the blood-testis barrier (BTB). حسب Lingjun Zhao (21763122)

الموضوعات:

Effects of busulfan treatment on CX43 and N-Cadherin. حسب Lingjun Zhao (21763122)

الموضوعات:

Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. حسب Claire M. Douglas (21238238)

الموضوعات:

Participant demographic and clinical characteristics. حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... حسب Claire M. Douglas (21238238)

الموضوعات:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... حسب Claire M. Douglas (21238238)

الموضوعات: